ERBB2 and breast carcinoma: Human epidermal growth factor receptor HER3 (ErbB3), a cell membrane-associated protein encoded by the ERBB3 gene, is a promising target for cancer therapy, especially in HER2-positive (carrying ERBB2/HER2 gene amplification) breast carcinoma [1].